Single-session vs multiple-session pattern scanning laser panretinal photocoagulation in proliferative diabetic retinopathy: The Manchester Pascal Study.

OBJECTIVE To investigate the effects of pattern scanning laser (Pascal; OptiMedica, Santa Clara, California) multispot panretinal photocoagulation given in a single-session (SS-PRP) vs single-spot multiple-session PRP (MS-PRP) on proliferative diabetic retinopathy (PDR). METHODS Single-center, randomized clinical trial of 40 eyes. Proliferative diabetic retinopathy was treated with a 400-mum spot size in 1500 burns given either as Pascal in 20-millisecond SS-PRP or in 3 sessions (100-millisecond MS-PRP) during a 4-week period. Visual acuity, central subfield retinal thickness (CRT), and 24-2 Swedish interactive thresholding algorithm visual fields were recorded at baseline and 4 and 12 weeks. MAIN OUTCOME MEASURES Central subfield retinal thickness, mean deviation, and PDR grade at 12 weeks. RESULTS There was a significant increase in mean CRT with MS-PRP (22 mum at 4 weeks, 95% CI, -32.25 to -10.75; 20 mum at 12 weeks, 95% CI, -28.75 to -10.82; P < .001) and no significant increase in the SS-PRP group. The mean deviation increased significantly in the SS-PRP group after 4 weeks (0.73 dB, P = .048), with no significant changes in either group at other points. A positive effect on PDR was observed in 74% of eyes in the SS-PRP group vs 53% in the MS-PRP group (P = .31). Mean treatment time for SS-PRP was 5.04 minutes (SD, 1.5 minutes) compared with 59.3 (SD, 12.7 minutes) in the MS-PRP group (P < .001). CONCLUSIONS There were no adverse outcomes (CRT, visual acuity, or visual field) from using multispot SS-PRP vs single-spot MS-PRP at 12 weeks postlaser, and treatment times were significantly shorter for multispot SS-PRP. Pascal SS-PRP was as effective as MS-PRP in the treatment of PDR. APPLICATION TO CLINICAL PRACTICE Twenty-millisecond Pascal SS-PRP may be safely and rapidly performed in 1500 burns with a similar efficacy to conventional MS-PRP. TRIAL IDENTIFIER: Research and Development Office PIN R00037, Central Manchester University Hospitals Foundation Trust.

[1]  N. Bressler,et al.  Observational study of the development of diabetic macular edema following panretinal (scatter) photocoagulation given in 1 or 4 sittings. , 2009, Archives of ophthalmology.

[2]  Atul K. Jain,et al.  Healing of retinal photocoagulation lesions. , 2008, Investigative ophthalmology & visual science.

[3]  P. Stanga,et al.  Initial experience with the Pascal photocoagulator: a pilot study of 75 procedures , 2008, British Journal of Ophthalmology.

[4]  M. Blumenkranz,et al.  SEMIAUTOMATED PATTERNED SCANNING LASER FOR RETINAL PHOTOCOAGULATION , 2006, Retina.

[5]  S. Kishi,et al.  PROGRESSIVE ENLARGEMENT OF SCATTERED PHOTOCOAGULATION SCARS IN DIABETIC RETINOPATHY , 2004, Retina.

[6]  Reginald Birngruber,et al.  Influence of pulse duration and pulse number in selective RPE laser treatment , 2004, Lasers in surgery and medicine.

[7]  Tetsuya Kano,et al.  Quantifying alterations of macular thickness before and after panretinal photocoagulation in patients with severe diabetic retinopathy and good vision. , 2003, Ophthalmology.

[8]  Y. Ogura,et al.  Inflammatory response after scatter laser photocoagulation in nonphotocoagulated retina. , 2002, Investigative ophthalmology & visual science.

[9]  B A Rockwell,et al.  Pathology of macular lesions from subnanosecond pulses of visible laser energy. , 1997, Investigative ophthalmology & visual science.

[10]  A. Heijl,et al.  The effect of panretinal laser photocoagulation on visual acuity, visual fields and on subjective visual impairment in preproliferative and early proliferative diabetic retinopathy , 1994, Acta ophthalmologica.

[11]  H. Bazan,et al.  Production of platelet-activating factor in photocoagulated retinas. , 1991, Current eye research.

[12]  H. Schatz,et al.  Visual loss following panretinal photocoagulation for proliferative diabetic retinopathy. , 1985, Ophthalmology.

[13]  B. Doft,et al.  Single versus multiple treatment sessions of argon laser panretinal photocoagulation for proliferative diabetic retinopathy. , 1982, Ophthalmology.

[14]  Zweng Hc,et al.  Complications of argon laser photocoagulation. , 1974 .

[15]  Atul K. Jain,et al.  Effect of pulse duration on size and character of the lesion in retinal photocoagulation. , 2008, Archives of ophthalmology.

[16]  D. Pahor.  Visual field loss after argon laser panretinal photocoagulation in diabetic retinopathy: full- versus mild-scatter coagulation , 2004, International Ophthalmology.

[17]  P. Stanga,et al.  Micropulse laser in the treatment of diabetic macular edema. , 1999, Seminars in ophthalmology.

[18]  A. G. Casswell,et al.  What effect does laser photocoagulation have on driving visual fields in diabetics? , 1998, Eye.

[19]  S A Vernon,et al.  Passing the DVLC field regulations following bilateral pan-retinal photocoagulation in diabetics , 1992, Eye.

[20]  L. Benjamin,et al.  Fields, DVLC and panretinal photocoagulation , 1992, Eye.

[21]  Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group. , 1991, Ophthalmology.

[22]  TECHNIQUES FOR SCATTER AND LOCAL PHOTOCOAGULATION TREATMENT OF DIABETIC RETINOPATHY: EARLY TREATMENT DIABETIC RETINOPATHY STUDY REPORT NO. 3 , 1987, International ophthalmology clinics.

[23]  H. Schatz.  MACULAR EDEMA FOLLOWING PANRETINAL PHOTOCOAGULATION , 1985, Retina.